Inventor · disambiguated record
Ester Fernandez-Salas
Also filed as: FERNANDEZ-SALAS ESTER · FERNANDEZ-SALAS ESTER G
77 granted patents·50 pending applications·1,664 citations·filing 2001–2024
99Inventor score
Files withALLERGAN INC85STEWARD LANCE E15FERNANDEZ-SALAS ESTER11JACKY BIRGITTE P S6UNIV MICHIGAN REGENTS4
Top patents by PatentIndex Score
127 records- 0199US7897157B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Mar 1, 2011·62 cites·29 claims
- 0299US7749514B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jul 6, 2010·64 cites·19 claims
- 0398US11332518B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2021·Granted May 17, 2022·7 cites·30 claims
- 0498US7811584B2Multivalent clostridial toxinsALLERGAN INC·Filed 2008·Granted Oct 12, 2010·79 cites·12 claims
- 0598US7740868B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jun 22, 2010·63 cites·34 claims
- 0698US7718766B2Fret protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2008·Granted May 18, 2010·37 cites·19 claims
- 0798US7709608B2Substrates useful for FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted May 4, 2010·37 cites·33 claims
- 0898US7645570B2Botulinum toxin screening assaysALLERGAN INC·Filed 2008·Granted Jan 12, 2010·68 cites·20 claims
- 0998US7598027B2Botulinum toxin screening assaysALLERGAN INC·Filed 2005·Granted Oct 6, 2009·61 cites·29 claims
- 1098US7495069B2FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted Feb 24, 2009·52 cites·30 claims
- 1198US7332567B2Fret protease assays for clostridial toxinsALLERGAN INC·Filed 2001·Granted Feb 19, 2008·96 cites·131 claims
- 1298US7208285B2Fret protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2001·Granted Apr 24, 2007·117 cites·88 claims
- 1398US7183066B2Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxinsALLERGAN INC·Filed 2002·Granted Feb 27, 2007·126 cites·39 claims
- 1497US11261240B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2020·Granted Mar 1, 2022·7 cites·16 claims
- 1597US8198034B2Immuno-based botulinum toxin serotype A activity assaysFERNANDEZ-SALAS ESTER·Filed 2009·Granted Jun 12, 2012·63 cites·25 claims
- 1697US8071110B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Dec 6, 2011·32 cites·13 claims
- 1797US7846722B2Luminescence resonance energy transfer (LRET) assays for clostridial toxin activityALLERGAN INC·Filed 2007·Granted Dec 7, 2010·55 cites·18 claims
- 1897US7749759B2Cell compositions useful for cell-based FRET assays for clostridial toxinsALLERGAN INC·Filed 2008·Granted Jul 6, 2010·39 cites·61 claims
- 1997US7678550B1FRET protease assays for botulinum serotype A/E toxinsALLERGAN INC·Filed 2006·Granted Mar 16, 2010·35 cites·41 claims
- 2097US7223577B2Post-translational modifications and Clostridial neurotoxinsALLERGAN INC·Filed 2005·Granted May 29, 2007·48 cites·8 claims
- 2196US8124357B2Lipophilic dye-based fret assays for clostridal toxin activityFERNANDEZ-SALAS ESTER·Filed 2006·Granted Feb 28, 2012·36 cites·17 claims
- 2295US10703806B2Immuno-based botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2017·Granted Jul 7, 2020·10 cites·4 claims
- 2395US8623999B2Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2012·Granted Jan 7, 2014·27 cites·3 claims
- 2495US8361789B2Cells useful for immuno-based Botulinum toxin serotype A activity assaysALLERGAN INC·Filed 2010·Granted Jan 29, 2013·13 cites·5 claims
- 2595US8052979B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsALLERGAN INC·Filed 2006·Granted Nov 8, 2011·30 cites·16 claims
- 2694US9249216B2Immuno-based botulinum toxin serotype A activity assaysFERNANDEZ-SALAS ESTER·Filed 2012·Granted Feb 2, 2016·23 cites·4 claims
- 2794US8128940B2Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2006·Granted Mar 6, 2012·25 cites·5 claims
- 2894US7993656B2Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cellsALLERGAN INC·Filed 2007·Granted Aug 9, 2011·22 cites·5 claims
- 2993US10501731B2Degradable clostridial toxinsALLERGAN INC·Filed 2017·Granted Dec 10, 2019·6 cites·3 claims
- 3093US9943576B2Formulations of biologics for intravesical instillationALLERGAN INC·Filed 2015·Granted Apr 17, 2018·10 cites·9 claims
- 3193US8841111B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Sep 23, 2014·9 cites·1 claims
- 3293US8697414B2Degradable clostridial toxinsALLERGAN INC·Filed 2013·Granted Apr 15, 2014·9 cites·2 claims
- 3393US8273358B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Sep 25, 2012·11 cites·9 claims
- 3493US8021859B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsALLERGAN INC·Filed 2008·Granted Sep 20, 2011·19 cites·13 claims
- 3593US7892565B2Degradable clostridial toxinsALLERGAN INC·Filed 2005·Granted Feb 22, 2011·19 cites·29 claims
- 3693US7491799B2Modified botulinum neurotoxinsALLERGAN INC·Filed 2004·Granted Feb 17, 2009·34 cites·3 claims
- 3792US8455203B2Immuno-based retargeted endopeptidase activity assaysWANG JOANNE·Filed 2010·Granted Jun 4, 2013·23 cites·1 claims
- 3892US7998489B2Degradable clostridial toxinsALLERGAN INC·Filed 2008·Granted Aug 16, 2011·17 cites·2 claims
- 3991US10345306B2Immuno-based retargeted endopeptidase activity assaysALLERGAN INC·Filed 2017·Granted Jul 9, 2019·4 cites·17 claims
- 4091US8518417B1Modified clostridial toxins with enhanced translocation capability and enhanced targeting activitySTEWARD LANCE E·Filed 2007·Granted Aug 27, 2013·14 cites·1 claims
- 4191US8273865B2Multivalent clostridial toxinsSTEWARD LANCE E·Filed 2010·Granted Sep 25, 2012·8 cites·13 claims
- 4291US8022172B2Luminescence resonance energy transfer (LRET) assays for clostridial toxin activityALLERGAN INC·Filed 2007·Granted Sep 20, 2011·10 cites·27 claims
- 4389US8535941B2Lipophilic dye-based FRET assays for clostridial toxin activityFERNANDEZ-SALAS ESTER·Filed 2012·Granted Sep 17, 2013·6 cites·19 claims
- 4489US7825233B2Optimizing expression of active Botulinum Toxin type EALLERGAN INC·Filed 2005·Granted Nov 2, 2010·13 cites·5 claims
- 4588US9651553B2Immuno-based retargeted endopeptidase activity assaysALLERGAN INC·Filed 2015·Granted May 16, 2017·3 cites·4 claims
- 4688US8512992B2Degradable clostridial toxinsSTEWARD LANCE E·Filed 2011·Granted Aug 20, 2013·5 cites·1 claims
- 4788US8067231B2Clostridial toxin activity assaysFERNANDEZ-SALAS ESTER·Filed 2006·Granted Nov 29, 2011·13 cites·19 claims
- 4888US8013113B2FRET protease assays for clostridial toxinsALLERGAN INC·Filed 2009·Granted Sep 6, 2011·2 cites·15 claims
- 4988US8003753B2Fret protease assays for clostridial toxinsALLERGAN INC·Filed 2009·Granted Aug 23, 2011·6 cites·14 claims
- 5088US7534863B2Leucine-based motifs and enhanced biological persistence of clostridial neurotoxinsALLERGAN INC·Filed 2004·Granted May 19, 2009·15 cites·3 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →